Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology

Abstract Purpose  The effective delivery of short interfering RNA (siRNA) to brain following intravenous administration requires the development of a delivery system for transport of the siRNA across the brain capillary endothelial wall, which forms the blood–brain barrier in vivo.